The synthesis and evaluation of cyclic ureas as HIV protease inhibitors:: Modifications of the P1/P1′ residues

被引:29
|
作者
Patel, M
Bacheler, LT
Rayner, MM
Cordova, BC
Klabe, RM
Erickson-Viitanen, S
Seitz, SP
机构
[1] Dupont Merck Pharmaceut Co, Expt Stn, Dept Chem & Phys Sci, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Expt Stn, Dept Virol, Wilmington, DE 19880 USA
关键词
D O I
10.1016/S0960-894X(98)00119-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two series of cyclic ureas modified at the P1/P1' residue were prepared and evaluated for HIV protease inhibition and whole cell antiviral activity. Compounds 8b, 10 (3- and 4-pyridylmethyl analogs) and 6b (4-methoxy analog) showed significant improvement in antiviral activity relative to lead compounds DMP323 and DMP 450. (C) 1998 The DuPont Merck Pharmaceutical Company. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 50 条
  • [41] Virtual complete intersections in P1 x P1
    Gao, Jiyang
    Li, Yutong
    Loper, Michael C.
    Mattoo, Amal
    JOURNAL OF PURE AND APPLIED ALGEBRA, 2021, 225 (01)
  • [42] P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1
    Kim, RM
    Rouse, EA
    Chapman, KT
    Schleif, WA
    Olsen, DB
    Stahlhut, M
    Rutkowski, CA
    Emini, EA
    Tata, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (18) : 4651 - 4654
  • [43] Invariant curves for endomorphisms of P1 x p1
    Pakovich, Fedor
    MATHEMATISCHE ANNALEN, 2023, 385 (1-2) : 259 - 307
  • [44] Good reduction of certain covers P1→P1
    Zannier, U
    ISRAEL JOURNAL OF MATHEMATICS, 2001, 124 (1) : 93 - 114
  • [45] Bound on Seshadri constants on P1 x P1
    De Volder, Cindy
    Tutaj-Gasinska, Halszka
    BULLETIN OF THE BELGIAN MATHEMATICAL SOCIETY-SIMON STEVIN, 2009, 16 (05) : 823 - 829
  • [46] Rational curves on K3 surfaces in P1 x P1 x P1
    Baragar, A
    PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 1998, 126 (03) : 637 - 644
  • [47] Segre-Veronese embeddings of P1 x P1 x P1 and their secant varieties
    Catalisano, M. V.
    Geramita, A. V.
    Gimigliano, A.
    COLLECTANEA MATHEMATICA, 2007, 58 (01) : 1 - 24
  • [48] Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1′-P2′ ligands
    Ghosh, Arun K.
    Fyvie, W. Sean
    Brindisi, Margherita
    Steffey, Melinda
    Agniswamy, Johnson
    Wang, Yuan-Fang
    Aoki, Manabu
    Amano, Masayuki
    Weber, Irene T.
    Mitsuya, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (21) : 4925 - 4931
  • [49] Potent and selective aggrecanase inhibitors containing cyclic P1 substituents
    Cherney, RJ
    Mo, RW
    Meyer, DT
    Wang, L
    Yao, WQ
    Wasserman, ZR
    Liu, RQ
    Covington, MB
    Tortorella, MD
    Arner, EC
    Qian, MX
    Christ, DD
    Trzaskos, JM
    Newton, RC
    Magolda, RL
    Decicco, CP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (07) : 1297 - 1300
  • [50] Synthesis of P1′-Functionalized Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol
    De Rosa, Maria
    Unge, Johan
    Motwani, Hitesh V.
    Rosenquist, Asa
    Vrang, Lotta
    Wallberg, Hans
    Larhed, Mats
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6444 - 6457